The new design is a screw-cage hybrid intended to facilitate insertion and osseointegration, according to a Jan. 23 news release. The device is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix added more graft space, while maintaining the product’s biomechanical and pull-out strength. An orthopedic spine surgeon developed the device with input from pain management and interventional physicians.
The company said it has performed more than 20 labs in 2020 and five labs so far in 2021.
Sacrix is a portfolio company of KICVentures Group, which acquired NanoFuse Biologics in December.
More articles on devices:
Spine surgeon, inventor files patent infringement suit against NuVasive
14 key thoughts on bundled payments in spine surgery
Flexibility, patience & financial stability — 5 spine surgeons on lessons learned in 2020
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
